Beam Therapeutics

/Beam Therapeutics

We are a biotechnology company committed to creating a new class of precision genetic medicines based on our proprietary base editing technology, with a vision of providing life-long cures to patients suffering from serious diseases.

Symbol

Price Range
$15.00 - $17.00

Final Shares
6,250,000

Anticipated Date
February 6, 2020

Underwriters

This offering is no longer available

To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange